2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

503. Clonal Hematopoiesis, Aging, and Inflammation: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Molecular Testing, Omics Technologies, Pathology, Bioinformatics, Computational Biology, Emerging Technologies, Gene Editing, Profiling, Treatment Considerations, Combination Therapy, Biological Processes, Pathogenesis, CHIP, Genomics, Hematopoiesis, Immune Mechanism, Molecular Biology, Diseases, Bleeding and Clotting, Thromboembolism, Bone Marrow Failure Syndromes, Immunology, White Blood Cell Disorders, Lymphoid Malignancies, Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, Translational Research, MDS, MPN, Clinical Research, Epidemiology, Health Outcomes Research, Real-World Evidence, Study Population, Human, Adult, Animal Model
PAPER

4895 APOBEC3C induces RNA editing and RNA splicing changes associated with clonal hematopoiesis

Inge Van Der Werf, PhD, Jane Isquith2, Emma E Klacking, BS3, Jessica Pham4, Wenxue Ma5, Shuvro Nandi6, Rongjie Wu7, Claire Engstrom8, Kendale Wirtjes9, Anna Khachatrian10, Thomas Whisenant, PhD11, Ludmil Alexandrov12, Catriona Jamieson, MD, PhD13
1 University of California San Diego, La Jolla, California, United States
2 University of California San Diego, La Jolla, California, United States
3 University of California San Diego, La Jolla, California, United States
4 University of California San Diego, La Jolla, California, United States
5 University of California San Diego, La Jolla, California, United States
6 University of California, San Diego, La Jolla, United States
7 University of California, San Diego, La Jolla, United States
8 University of California San Diego, La Jolla, California, United States
9 University of California San Diego, La Jolla, California, United States
10 Scripps Health, La Jolla, United States
11 University of California, San Diego, La Jolla, United States
12 University of California, San Diego, La Jolla, United States
13 University of California San Diego, La Jolla, California, United States

Inflammatory-responsive APOBEC3 base deaminase enzymes catalyze C-to-U editing of DNA and RNA, yet the functional consequences of APOBEC3-mediated RNA editing remain poorly understood. We previously demonstrated that inflammatory cytokine signaling and stressors associated with aging, microgravity, and other fight-or-flight responses induce APOBEC3C activation in HSPCs, coinciding with the emergence of stress-induced clonal hematopoiesis (CH). Moreover, our multi-omic analyses of myeloproliferative neoplasm (MPN) HSPCs identified APOBEC3C as the predominantly expressed APOBEC3 family member, suggesting a context-specific role in hematopoietic stem cell biology.

In this study, we collected healthy cord blood (CB) and aged bone marrow (ABM), isolated CD34⁺ hematopoietic stem and progenitor cells (HSPCs), and lentivirally transduced them with APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, or pCDH vector controls. Single-cell RNA sequencing and whole-transcriptome sequencing were performed to quantify C-to-U RNA editing, differential gene expression, and RNA splicing, alongside whole-genome sequencing to assess C-to-T DNA mutagenesis. Based on the extensive RNA splicing alterations and dysregulation of clonal hematopoiesis-associated genes induced by APOBEC3C, we performed dual fluorescent splicing reporter assays, survival and self-renewal assays, and in vivo engraftment studies.

While APOBEC3 family members varied in their capacity to induce genomic instability, they uniformly perturbed RNA biology, including RNA splicing and RNA metabolism-related pathways. APOBEC3C induced the most pronounced transcriptomic effects in aged bone marrow (ABM) HSPCs, resulting in a 10-fold increase in differentially expressed genes compared with cord blood (CB) HSPCs. These included altered expression of and spliceosome components implicated in clonal hematopoiesis (CH), myeloproliferative neoplasms (MPNs), and myelodysplastic syndromes (MDS), including U2AF1, ZRSR2, and SF3B2. . Using our MAPT dual fluorescence splicing reporter assay, we identified significantly increased GFP and RFP signals suggesting increased RNA splicing reporter, we observed a significant decrease in the ratio of RFP to GFP, indicative of increased exon skipping in ABM HSPCs upon APOBEC3C lentiviral transduction. Moreover, in ABM HSPCs, APOBEC3C was found to affect CH–associated transcripts, including DNMT3A, enhance ADAR1-mediated RNA editing and IL-6/JAK2/STAT signaling, and increase progenitor expansion. Preliminary in vivo studies further demonstrated increased engraftment of APOBEC3C-expressing CD34⁺ myelofibrosis HSPCs following 20 weeks of transplantation. 

In conclusion, these findings demonstrate that APOBEC3C modulates RNA splicing and C-to-U RNA editing in CB-derived HSPCs, with substantially more pronounced effects in ABM-derived HSPCs. In aged HSPCs, APOBEC3C activation is associated with increased ADAR1p150 expression, elevated A-to-I RNA editing, activation of IL-6/JAK-STAT inflammatory signaling, and enhanced HSPC expansion, which together may contribute to the pathogenesis and progression of myeloid disorders. Moreover, these findings suggest that APOBEC3C activation may amplify inflammatory signaling through an IL-6/JAK2/STAT-associated feedback mechanism, reinforcing RNA dysregulation and HSPC expansion during clonal evolution.

Inge Van Der Werf, PhD: No relevant conflicts of interest to declare.